Migraine is a neurovascular syndrome characterized by throbbing unilateral headache and often a premonitory prodrome or aura, nausea, vomiting, photophobia, blurry vision, and GI and other unpleasant symptoms. Almost three times more women than men suffer from migraine. Although many triggers of migraine episodes have been identified, the pathophysiology of the disorder is not clear.
Migraine may involve release of monoamines and vasoactive peptides from trigeminal neurons and structures in the brainstem, which first cause cerebral vasoconstriction and then vasodilation, the latter associated with neurogenically induced inflammation and increased expression of COX-2 in some brain areas. 5-HT appears to be involved in migraine episodes, possibly by facilitating neuronal release of vasoactive substances, directly affecting the tone of cerebral vessels, or by activating cranial nociceptors. Read more information that is not included here, visit Pharma Mirror Magazine.
